Justin Mikell

Justin Mikell, PhD is an Associate Professor of Radiation Oncology and Associate Professor of Radiology at Washington University School of Medicine, where he is part of the Division of Medical Physics within the Siteman Cancer Center. He joined Washington University in 2022 after previously holding a faculty position at the University of Michigan, where he was part of the brachytherapy and machine QA teams.

Dr. Mikell earned his dual BS degrees in Engineering and Computer Science from the University of Illinois, Urbana-Champaign (2002), followed by a PhD in Medical Physics from the University of Texas at Houston Graduate School of Biomedical Sciences and UT MD Anderson Cancer Center (2015). He completed his residency in Medical Physics at the University of Michigan, Ann Arbor (2018).

His research focuses on combination radiotherapy, quantitative emission imaging, and absorbed dose calculations for both microspheres and unsealed sources, particularly Y-90 microspheres. His work has significantly advanced the field of radioembolization for liver cancer treatment, with a special emphasis on precise dosimetry modeling and treatment planning. Dr. Mikell's expertise spans medical physics, radiation oncology, and nuclear medicine, allowing him to bridge these disciplines for improved patient outcomes.

Dr. Mikell's publication record demonstrates consistent contributions to the field, with research spanning from technical aspects of dosimetry calculation to clinical applications in liver cancer treatment. His recent work shows increasing focus on integrating advanced imaging techniques like PET/CT with precise dose calculation methods, and exploring combination therapies involving radioembolization and stereotactic body radiation therapy.

With approximately 1,200 citations across his 47 research outputs, Dr. Mikell has established himself as a significant contributor to the field of radiation oncology physics, particularly in the area of radioembolization dosimetry and treatment planning.

He continues to collaborate extensively with nuclear medicine colleagues and radiation oncologists, advancing research in quantitative imaging for radiation therapy and developing more precise methods for calculating and delivering therapeutic radiation doses to cancer patients.